TÌNH HÌNH SỬ DỤNG THUỐC TRÊN BỆNH NHÂN ĐÁI THÁO ĐƯỜNG TÝP 2 CÓ TĂNG HUYẾT ÁP ĐIỀU TRỊ NỘI TRÚ TẠI BỆNH VIỆN ĐA KHOA ĐẦM DƠI, TỈNH CÀ MAU NĂM 2022-2023

Abstract

Background: Type 2 diabetes and hypertension are two increasingly common diseases, the progression can be independent or related to each other, requiring long-term drug treatment. Objective: To investigate drug use in inpatients with type 2 diabetes mellitus with hypertension at Dam Doi General Hospital, Ca Mau province, 2022-2023. Materials and methods: A cross-sectional descriptive study on 261 inpatient medical records of type 2 diabetes patients with hypertension at Dam Doi General Hospital, Ca Mau province, from 2022 to 2023. Results: 4 groups of drugs for type 2 diabetes were used and the insulin group accounted for the most (63.6%). During the treatment of type 2 diabetes, 248/261 (95.0%) patients were fixed on a regimen and 13/261 (5.0%) patients changed regimen once. For the use of antihypertensive drugs, a total of 5 drug groups were used and Angiotensin II was used the most with the rate of 74.7%. During the treatment of high blood pressure, 242/261 (92.7%) patients were fixed 1 regimen and 17/261 (6.5%) patients changed regimen 1 time and 2/ 261 (0.8%) patients changed regimen up to 2 times in treatment. Conclusion: At Dam Doi General Hospital, Ca Mau province, insulin and angiotensin II groups were used the most in patients with type 2 diabetes and hypertension. Monotherapy regimens accounted for the majority (over 92%) during inpatient treatment in this group of patients.